The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure.
D000818:Animals; D002135:Calcium-Binding Proteins; D002478:Cells, Cultured; D020672:I-kappa B Proteins / Q000032:analysis; D018799:Intercellular Adhesion Molecule-1 / Q000032:analysis; D007371:Interferon-gamma / Q000494:pharmacology; D007511:Ischemia / Q000378:metabolism / Q000517:prevention & control*; D007668:Kidney / Q000737:chemistry / Q000378:metabolism; D007674:Kidney Diseases / Q000378:metabolism / Q000517:prevention & control*; D007684:Kidney Tubules / Q000187:drug effects; D008070:Lipopolysaccharides / Q000494:pharmacology; D008297:Male; D008562:Membrane Glycoproteins / Q000032:analysis; D023421:Models, Animal; D016328:NF-kappa B / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000032:analysis; D009569:Nitric Oxide / Q000032:analysis; D019001:Nitric Oxide Synthase / Q000032:analysis; D052247:Nitric Oxide Synthase Type II; D015230:Prostaglandin D2 / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000378:metabolism / Q000517:prevention & control; D050863:Synaptotagmin I; D050857:Synaptotagmins; D013997:Time Factors
C097240:15-deoxy-delta(12,14)-prostaglandin J2; D002135:Calcium-Binding Proteins; D020672:I-kappa B Proteins; D008070:Lipopolysaccharides; D008562:Membrane Glycoproteins; D016328:NF-kappa B; D009419:Nerve Tissue Proteins; D050863:Synaptotagmin I; D018799:Intercellular Adhesion Molecule-1; D050857:Synaptotagmins; D009569:Nitric Oxide; D007371:Interferon-gamma; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496318:Nos2 protein, rat; D015230:Prostaglandin D2